Were talking about 0.5% to 1% volume effect 10 years down the road and that assumes quite significant adoption rates of the drug
But before Davis could fill it, his company added a new requirement
Your doctor may also need to monitor you closely for the meantime
Orforglipron is an oral GLP-1 medication, acting on systems involved in hunger, fullness, and digestion
It regulates actin, the structural protein that cells need to migrate, reorganize, and repair damaged tissue
To view or add a comment, sign in More Relevant Posts The 2026 ADA Standards of Care mark a continued evolution in diabetes pharmacotherapy, more formally incorporating GLP-1 receptor agonists into organ-specific treatment algorithms